InvestmentCordenPharma invests €900m in peptide patform expansionLatest NewsCordenPharma is making a record investment of about €900m over the next three years in expanding its peptide platform, both at its Colorado, US site and in Europe. Read more 16 July 2024 https://european-biotechnology.com/wp-content/uploads/2024/07/CordenPharma-Peptide-Expansion-Press-Release-16-July-2024-for-Web-1-1024x614.jpg 614 1024 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-07-16 10:19:442024-07-16 18:19:35CordenPharma invests €900m in peptide patform expansion